跳至主要内容
临床试验/NL-OMON34258
NL-OMON34258尚未招募不适用

Validation of cholesterol absorption as measured by the dual isotope method - DAHLIA-2B

Academisch Medisch Centrum0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy male and female subjects, aged 18-65 years, with an LDL-cholesterol concentration between 3.0 and 5.0 mmol/l, who participated in the Dahlia-2a study and who do not use any cholesterol-lowering medication.

排除标准

  • Excluded are persons with a genetic hyperlipoproteinemia like familial hypercholesterolemia, LPL-deficiency, familial dysbeta lipoproteinemia and familial hypertriglyceridemia. Also people with diabetes mellitus, severe hypertriglyceridemia, uncontrolled hypertension or history of arterial disease including unstable angina, myocardial infarction, recent transient ischaemic attacks or a cerebro-vascular accidents, will be excluded.

研究者

相似试验

已完成
4 期
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSoundpatients aged 30-85 years who were undergoing percutaneous coronary intervention (PCI, elective or emergency) with &gt=1 significant stenosis &gt=75% and &gt=1 untouched nonculprit lesion of &lt=50% stenosis that could be imaged by intravascular ultrasound, and either LDL-C &gt=100 mg/dl.
JPRN-UMIN000002959Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University300
已完成
不适用
The study about the effects of cholesterol absorption inhibition on coronary artery plaque in patients treated with PCIcoronary artery diseases
JPRN-UMIN000026581Kurume University Medical Center50
已完成
4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease Hypercholesterolemia
JPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50
招募中
不适用
Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases.ormal subjects, Diabetes, Hyperlipidemia, Essential hypertension, Metabolic syndrome
JPRN-UMIN000004946Department of Metabolic Medicine, Faculty of life sciences, Kumamoto University600
尚未招募
不适用
The difference in fractional cholesterol absorption between subjects with high versus low plasma campesterol levelsmild hypercholesterolaemiaslightly elevated cholesterol10013317
NL-OMON32507Academisch Medisch Centrum13